SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-194179
Filing Date
2023-07-26
Accepted
2023-07-26 09:05:57
Documents
8
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d442934ddef14a.htm DEF 14A 836756
2 GRAPHIC g442934dsp018.jpg GRAPHIC 119893
3 GRAPHIC g442934dsp019.jpg GRAPHIC 208745
4 GRAPHIC g442934dsp020.jpg GRAPHIC 191973
5 GRAPHIC g442934dsp021.jpg GRAPHIC 190058
6 GRAPHIC g442934g00a02.jpg GRAPHIC 36409
7 GRAPHIC g442934g00a58.jpg GRAPHIC 85164
8 GRAPHIC g442934g00a59.jpg GRAPHIC 76091
  Complete submission text file 0001193125-23-194179.txt   2066280
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 231110240
SIC: 3841 Surgical & Medical Instruments & Apparatus